(Q44279400)

1 December 2017

title

Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice (English)

1 reference

1 December 2017

1 reference

2

1 reference

1 December 2017

6

Frankel AE

1 reference

1 December 2017

Black JH

1

1 reference

1 December 2017

Willingham MC

series ordinal

3

1 reference

1 December 2017

Ramage J

series ordinal

4

1 reference

1 December 2017

Hogge DE

series ordinal

5

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

155-159

1 reference

Acute myeloid leukemia in adults: where do we go from here?

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

The crystal structure of diphtheria toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Molecular characterization of key diphtheria toxin:receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

In vitro interleukin-3 binding to leukemia cells predicts cytotoxicity of a diphtheria toxin/IL-3 fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

7 January 2021

High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

7 January 2021

Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

7 January 2021

Targeting myeloid leukemia with a DT(390)-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402744

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402744

1 reference

Dimensions Publication ID

1 December 2017

1016839064

0 references

1 reference